Related Experiment Video
Updated: Feb 26, 2026

A Reporter Assay to Analyze Intronic microRNA Maturation in Mammalian Cells
Published on: June 16, 2022
Regulation of PLK1 through competition between hnRNPK, miR-149-3p and miR-193b-5p
Chang Hoon Shin1, Hong Lee1, Hye Ree Kim1
1Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul, Korea.
Abstract:
Polo-like kinase 1 (PLK1) is a critical regulator of cell cycle progression and apoptosis. However, its regulation remains poorly understood. In the present study, we investigated the molecular mechanism underlying the post-transcriptional regulation of PLK1. We observed that heterogeneous nuclear ribonucleoprotein K (hnRNPK) and PLK1 were positively associated in several different cancers and high expression levels of them correlated with poor prognosis in patients with cancer. Knockdown of hnRNPK resulted in reduced expression of PLK1, whereas conversely, PLK1 expression was increased in hnRNPK-overexpressing cells. We found that hnRNPK regulated PLK1 expression through KH1- and KH2-dependent interactions with the 3'UTR of PLK1 mRNA. In addition, microRNA-149-3p (miR-149-3p) and miR-193b-5p suppressed PLK1 expression by targeting the 3'UTR of PLK1 mRNA. MicroRNA-elicited enrichment of PLK1 mRNA in Ago2 immunoprecipitation was altered by the presence or absence of hnRNPK. Furthermore, the deletion of the cytosine (C)-rich sequences of the 3'UTR of PLK1 mRNA abolished the decreased PLK1 expression observed via hnRNPK silencing and administration of miRNAs, a finding that suggests that hnRNPK shares this C-rich motif with miR-149-3p and miR-193b-5p. We also found that downregulation of PLK1 by either silencing hnRNPK or overexpression of miR-149-3p and miR-193b-5p decreased clonogenicity and induced apoptosis. Our findings from this study demonstrate that hnRNPK regulates PLK1 expression by competing with the PLK1-targeting miRNAs, miR-149-3p and miR-193b-5p.
Insights
Heterogeneous nuclear ribonucleoprotein K (hnRNPK) regulates Polo-like kinase 1 (PLK1) expression by competing with microRNAs. This competition impacts cancer cell growth and apoptosis, offering new therapeutic targets.
Area of Science:
- Molecular Biology
- Cancer Biology
- RNA Biology
Background:
- Polo-like kinase 1 (PLK1) is crucial for cell cycle control and apoptosis.
- The post-transcriptional regulation of PLK1 is not well understood.
- hnRNPK is implicated in cancer, but its regulatory role in PLK1 expression is unclear.
Purpose of the Study:
- To elucidate the molecular mechanism of PLK1 post-transcriptional regulation.
- To investigate the role of heterogeneous nuclear ribonucleoprotein K (hnRNPK) in PLK1 expression.
- To identify microRNAs involved in PLK1 regulation and their interaction with hnRNPK.
Main Methods:
- Correlation analysis of hnRNPK and PLK1 expression in cancer tissues.
- hnRNPK knockdown and overexpression studies.
- RNA immunoprecipitation (RIP) assays.
- 3'UTR reporter assays.
- MicroRNA mimic and inhibitor transfections.
Main Results:
- hnRNPK expression positively correlates with PLK1 levels and poor prognosis in cancers.
- hnRNPK directly interacts with the PLK1 3'UTR, enhancing PLK1 expression.
- MicroRNAs miR-149-3p and miR-193b-5p suppress PLK1 by targeting its 3'UTR.
- hnRNPK competes with these microRNAs for binding to a shared C-rich motif in the PLK1 3'UTR.
- Downregulation of PLK1 via hnRNPK or miRNA manipulation reduces cancer cell clonogenicity and induces apoptosis.
Conclusions:
- hnRNPK acts as a positive regulator of PLK1 expression.
- hnRNPK competes with miR-149-3p and miR-193b-5p for binding to the PLK1 3'UTR.
- This regulatory axis of hnRNPK-miRNA-PLK1 influences cancer cell proliferation and survival.
Related Concept Videos
Negative Regulator Molecules
MicroRNAs
MicroRNAs
Regulation of Nuclear Protein Sorting
Abnormal Proliferation
PI3K/mTOR/AKT Signaling Pathway

